Treating asthma and comorbid allergic rhinitis in pregnancy

Journal of the American Board of Family Medicine

Volumn 20, Issue 3, 2007, Pages 289-298

  Yawn, Barbara ^a,c   Knudtson, Mary ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OLMSTED MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE; CHROMONE DERIVATIVE; CLEMASTINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DESLORATADINE; FLUNISOLIDE; FLUTICASONE; FORMOTEROL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; LONG ACTING DRUG; MOMETASONE FUROATE; MONTELUKAST; NEDOCROMIL; ORCIPRENALINE; PIRBUTEROL; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG; THEOPHYLLINE; TRIAMCINOLONE; UNINDEXED DRUG; ZAFIRLUKAST;

ALLERGIC RHINITIS; ASTHMA; CLINICAL FEATURE; COMORBIDITY; CORTICOSTEROID THERAPY; COUNSELING; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG SAFETY; FETOTOXICITY; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOTHERAPY; LOW DRUG DOSE; NONHUMAN; PREGNANCY; REVIEW; RISK ASSESSMENT; SMOKING CESSATION; TERATOGENICITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ASTHMA; COMORBIDITY; DRUG TOXICITY; FEMALE; HUMANS; PREGNANCY; RHINITIS, ALLERGIC, SEASONAL; UNITED STATES;

EID: 34249874022     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2007.03.060144     Document Type: Review

References (54)

1. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 2005;115:34-46.
2. Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 2003;13:317-24.
3. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Chapter 7: Asthma in pregnancy. Thorax 2003;58(Suppl 1):i47-50.
4. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003;58:691-706.
5. Blaiss MS. Rhinitis-asthma connection: epidemiologic and pathophysiologic basis. Allergy Asthma Proc 2005;26:35-40.
6. Mabry RL. Intranasal steroid injection during pregnancy. South Med J 1980;73:1176-9.
7. Mabry RL. Rhinitis of pregnancy. South Med J 1986;79:965-71.
8. Braman SS, Barrows AA, DeCotiis BA, et al. Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma. Chest 1987;91:671-4.
9. Greisner WA, III, Settipane RJ, Settipane GA. Coexistence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19:185-8.
10. Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301-4.
11. Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419-25.
12. Stelmach R, do Patrocinio TNM, Ribeiro M, et al. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 2005;128:3140-7.
13. Kircher S, Schatz M, Long L. Variables affecting asthma course during pregnancy. Ann Allergy Asthma Immunol 2002;89:463-6.
14. National Asthma Education and Prevention Program. Report of the Working Group on Asthma and Pregnancy: Management of Asthma During Pregnancy. NIH publication 93-3279. 1993 (cited April 2006).
15. Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999;20:209-13.
16. McDonald CF, Burdon JG. Asthma in pregnancy and lactation. A position paper for the Thoracic Society of Australia and New Zealand. Med J Aust 1996;165:485-8.
17. Passalacqua G, Albano M, Canonica GW, et al. Inhaled and nasal corticosteroids: safety aspects. Allergy 2000;55:16-33.
18. Gluck JC, Gluck PA. Asthma controller therapy during pregnancy. Am J Obstet Gynecol 2005;192:369-80.
19. Schatz M, Harden K, Forsythe A, et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol 1988;81:509-17.
20. Mazzotta P, Loebstein R, Koren G. Treating allergic rhinitis in pregnancy: safety considerations. Drug Safety 1999;20:361-75.
21. Chambers K. Asthma education and outcomes for women of childbearing age. Case Manager 2003;14:58-61.
22. Murphy VE, Gibson PG, Talbot PI, et al. Asthma self-management skills and the use of asthma education during pregnancy. Eur Respir J 2005;26:435-41.
23. Schatz M, Leibman C. Inhaled corticosteroid use and outcomes in pregnancy. Ann Allergy Asthma Immunol 2005;95:234-8.
24. Incaudo GA. Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation. Clin Rev Allergy Immunol 2004;27:159-77.
25. Demoly P, Piette V, Daures J-P. Treatment of allergic rhinitis during pregnancy. Drugs 2003;63:1813-20.
26. Boulet L-P, Becker A, Bérubé D, et al. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 1999;161:S1-S61.
27. American Academy of Allergy Asthma and Immunology. Environmental Control. In: The Allergy Report. Vol I: Overview of Allergic Diseases: Diagnosis, Management, and Barriers to Care. Milwaukee, WI: American Academy of Allergy, Asthma and Immunology; 2000.
28. Dykewicz MS, Fineman S, Skoner DP, eds. Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:475-518.
29. Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-S334.
30. US Food and Drug Administration (FDA). U.S. FDA labeling and prescription drug advertising: content and format for labeling for human prescription drugs. Fed Regist 1979;44:37434-67.
31. Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol 2002;187:333-9.
32. TERIS: TERIS (The Teratogen Information System) Database. Seattle, WA: University of Washington. Updated periodically.
33. AstraZeneca LP. Rhinocort Aqua prescribing information, August 25, 2004.
34. AstraZeneca LP. Pulmicort Turbuhaler prescribing information, December 17, 2003.
35. Källén B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 1999;93:392-5.
36. Norjavaara E, de Verdier MG. Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide. J Allergy Clin Immunol 2003;111:736-42.
37. National Asthma Education and Prevention Program. Working Group Report on managing asthma during pregnancy: Recommendations for pharmacologic treatment. Update 2004. NIH publication No. 05-5236. Bethesda, MD: US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute.
38. FDA. FDA Public Health Advisory: Serevent Diskus (salmeterol xinafoate inhalation powder), Advair Diskus (fluticasone propionate and salmeterol inhalation powder), Foradil Aerolizer (formoterol fumarate inhalation powder). Last updated November 18, 2005.
39. American College of Obstetricians and Gynecologists and American College of Allergy Asthma and Immunology. The use of newer asthma and allergy medications during pregnancy. Ann Allergy Asthma Immunol. 2000;84:475-80.
40. Gilbert C, Mazzotta P, Loebstein R, et al. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf 2005;28:707-19.
41. Schatz M. H1-antihistamines in pregnancy and lactation. Clin Allergy Immunol 2002;17:421-36.
42. 1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ (Clinical Research Ed) 1998;317:1624-9.
43. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-34.
44. Nielsen LP, Mygind N, Dahl R. Intranasal corticosteroids for allergic rhinitis: superior relief? Drugs 2001;61:1563-79.
45. Yánez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002;89:479-84.
46. Spector SL. Overview of comorbid associations of allergic rhinitis. The Journal of Allergy and Clinical Immunology 99:S773-80, 1997.
47. Togias A. Mechanisms of nose-lung interaction. Allergy 1999;54 Suppl 57:94-105.
48. Källén BA, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003;17:255-61.
49. Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol 2001;26:394-400.
50. Palmer GW, Claman HN. Pregnancy and immunology: selected aspects. Ann Allergy Asthma Immunol 2002;89:350-9; 428.
51. Torfs CP, Katz EA, Bateson TF, et al. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 1996;54:84-92.
52. Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology 1992;45:361-7.
53. Knudtson M. Once-daily intranasal corticosteroids for allergic rhinitis, examining treatment issues. Adv Nurse Pract 2006;14:57-60.
54. Gluck PA, Gluck JC. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin 2005;21:1075-84.